Ursodeoxycholic acid is a secondary bile acid produced by intestinal bacteria in humans and most other species. It was first identified in bear bile and is used as an active pharmaceutical ingredient in formulations for liver and bile duct conditions.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 128-13-2
Ursodeoxycholylglycine
pharmaceutical raw material
Noscapine
pharmaceutical raw material
3-(Aminomethyl)-5-methylhexanoic acid
pharmaceutical raw material
(R)-citalopram
pharmaceutical raw material
Bivalirudin
pharmaceutical raw material
Allochenodeoxycholate
cholanoid
Sodium chenodeoxycholate
pharmaceutical raw material
Chenodiol
pharmaceutical raw material
(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
RUDATBOHQWOJDD-UZVSRGJWSA-N
C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C